🎁Free Samples Alert!✨ Try them for free and unlock your essential MedChemExpress products! 🔬 🌎North America 🇺🇸 🇨🇦 Unlock 12 categories, including Bioactive Molecules, Natural Products, ADC-Related, Recombinant Proteins, Antibodies, and Kits. 🔗ow.ly/lQJN50YCM2o 🌍EU & AP • Europe (including the UK🇬🇧) South Korea 🇰🇷, Singapore 🇸🇬, Malaysia 🇲🇾, Indonesia 🇮🇩, Australia 🇦🇺, New Zealand 🇳🇿, India 🇮🇳 • Access 14,000 Free Protein Samples • Up to 5 free samples per year 🔗medchemexpress.com/MCE-Free-… 🎯Click the links to explore your favorite products and claim yours today! ⬆️ #LifeScience #LabTools #DrugDiscovery #Biotech #ResearchMadeEasy #FreeSamples #BiotechTips

🎨Science Visuals | #Microglia were treated with #ST2825 and co-cultured with ependymal cells. Ependymal cells predominantly differentiated into neurons. 🧬#Immunofluorescence staining: 🟦 DAPI (nuclei) — 405 nm 🟩 Nestin — Alexa Fluor 488 🟥 DCX — Alexa Fluor 594 🟪 GFAP — Alexa Fluor 647 📸 Imaging system: Olympus FV-3000 FLIM 🔬 Final magnification: 20× 🧪MedChemExpress is committed to advancing scientific research. Reagents supporting this study: • ST2825 (HY-50937) • FGF-2 Protein, Mouse (HY-P7066) • EGF Protein, Mouse (HY-P70590) 📩We’d love to see how MedChemExpress products support your research. Share your #microscopy images with us in the comments or via DM to receive a special gift 🎁 #CellBiology #Neuroscience #Microglia #StemCells #ConfocalMicroscopy #LifeScience #CellCulture #ResearchTools #LabLife #ScienceCommunication

🔬New Releases | 1,000 Novel Research Molecules Now Available This release strengthens key areas across #Oncology, #Neurology, #Immunology & #Inflammation, #MetabolicDisease, supporting a broad range of drug discovery and basic research needs. Featured research areas include: ✔ #PROTAC-mediated targeted protein degradation ✔ RNA editing regulation (#ADAR1) ✔ Neuroinflammation & innate immunity (TREM2, NLRP3) ✔ Inflammatory signaling pathways (PDE4B, IL-36R, LPAR1) ✔ Bone metabolism regulation (RANKL) Many of these compounds feature desirable drug-like properties, including oral bioavailability, blood–brain barrier (#BBB) penetration, high selectivity, and favorable pharmacokinetic profiles—supporting target validation, mechanistic studies, and early-stage drug discovery. 🔬Empowering breakthrough research with high-quality bioactive molecules. medchemexpress.com/ #DrugDiscovery #Neuroinflammation #SmallMolecules #ResearchTools

🔥Hot Off the Press | LEAPER 2.0 & 3.0 #Cell (10 June 2026) publishes two LEAPER studies, marking a shift from proof-of-concept toward clinically relevant and structurally engineered RNA editing systems. LEAPER 2.0 advances endogenous adenosine deaminase acting on RNA (#ADAR)-mediated exon skipping in Duchenne muscular dystrophy (#DMD), extending it into nonhuman primate and early human studies. It shows durable dystrophin restoration, sustained functional benefit in NHPs, and early safety/efficacy signals in patients after a single AAV-delivered dose. ✔️ Circ-arRNAs enable exon skipping via endogenous ADAR activity ✔️ Durable dystrophin restoration in DMD NHPs without immune response ✔️ First-in-human data show safe, dose-dependent exon skipping LEAPER 3.0 introduces a structure-guided framework for programmable A-to-I RNA editing. By defining how RNA secondary structure regulates ADAR activity, it transforms arRNA design from empirical optimization into a rational, engineering-based process. ✔️ RNA structure (bulges and geometry) dictates ADAR efficiency and specificity ✔️ Protein-free, AAV-compatible, programmable RNA editing platform 🚀 Together, these studies highlight a new paradigm in which endogenous ADAR activity can be rationally programmed for therapeutic RNA editing. 🧪Some genetic diseases have well-defined mechanisms and actionable targets, creating strong opportunities for precision therapies such as RNA editing. Advancing RNA biology and genetic disease research relies on robust tools, including antibodies, recombinant proteins, and oligonucleotides. 👉Explore how we can support your research: ow.ly/6lgC50ZaXG3 #RNAEditing #LEAPER #RNAtherapeutics #GeneticDisease #Biotech #PrecisionMedicine

❓Tech Q&A |Why does Y15 fail to inhibit p-FAK in fibrosis models and LX-2 cells? 🔸Low basal p-FAK levels may trigger compensatory feedback activation, leading to increased FAK/p-FAK after Y15 treatment 🔸FAK inhibitors are typically more effective when p-FAK is already activated (e.g., established fibrosis models) 🔸Add a “fibrosis Y15” group to distinguish Y15 effects from those of the target compound 🔸In LX-2 cells, consider activating the FAK pathway first; weak p-FAK signals may also indicate WB optimization issues 🔸Check cell activation status, protein loading, lysis efficiency, and antibody conditions Refs: PMID: 27336608; 30326962; PMC: 11248270 #FAK #Fibrosis #CellSignaling #WesternBlot #TechQA

🔥Hot Off the Press | Intercellular DNA Transfer Can DNA move directly from one human cell to another? A new study suggests the answer may be yes. 🧬Researchers found that genomic instability—triggered by mitotic errors, radiation, or CRISPR-induced DNA breaks—can drive nuclear DNA transfer between neighboring cells via tunneling nanotube-like structures. Remarkably, transferred DNA can persist as extrachromosomal material and, in some cases, induce heritable phenotypic changes, suggesting a horizontal gene transfer–like process in mammalian cells mediated by direct cell–cell contact rather than viruses or vesicles. 💡Key implications: • Genome instability may extend beyond the originating cell • Direct cell connectivity could represent an underappreciated route for genetic remodeling • Somatic evolution in tissues, including cancer, may be more dynamic than previously recognized While these events appear rare in vitro, their implications are profound. The study challenges the long-standing view that genomes operate strictly within individual cellular boundaries, suggesting that genetic information may be more mobile and interconnected than previously thought. 🔬MedChemExpress provides a broad portfolio of tools to support research in DNA damage, intercellular communication, and somatic evolution. medchemexpress.com/ #GenomeInstability #DNATransfer #CellBiology #Genetics #CancerResearch #SomaticEvolution #MolecularBiology #LifeScience #DrugDiscovery

🔥Hot Off the Press | #Cardiometabolic #MLTC Cardiometabolic multiple long-term conditions (MLTC) arises from convergent perturbations across #metabolic, #inflammatory, and #vascular pathways, shaped by interacting biological, environmental, and social factors across the life course, driving disease patterns and trajectories. Key mechanisms include #insulin resistance, #adiposity, chronic #inflammation, and ectopic fat deposition, forming the biological basis of disease clustering. 🌍Environmental exposures Even low-level, long-term air pollution (PM2.5, NO₂) may accelerate disease progression. 👶Early-life determinants Undernutrition or overnutrition, gut microbiome disruption, and endocrine-disrupting chemicals can shape long-term metabolic and inflammatory trajectories. 🏙️Social context Social determinants of health further amplify metabolic and inflammatory dysregulation. 🧬Multi-layered biology Genetic susceptibility, epigenetic changes, and multi-omics perturbations contribute to disease heterogeneity and progression. Despite progress, most insights remain single-disease–focused, limiting understanding of causal pathways and population variation. Systems-level and translational research may improve precision prevention and outcomes. 🔬MedChemExpress provides a comprehensive portfolio of reagents and services to advance cardiometabolic research and drug discovery. ow.ly/wyc850Z9cF2 #Metabolism #PublicHealth #SystemsBiology #PrecisionMedicine #AirPollution #Multiomics

💡#FDA Approval Update | The FDA has approved #bemotrizinol (#BEMT) as the first new #sunscreen active ingredient added to the U.S. #OTC monograph in more than 20 years. 🧬Bemotrizinol is a broad-spectrum #UV filter that protects against both UVA and UVB radiation, exhibits low skin absorption, and has been widely used in Europe and other global markets for years. 🧪MedChemExpress offers bemotrizinol for research use only: medchemexpress.com/bemotrizi… #FDAApproval #Dermatology #Photobiology #DrugDiscovery #FormulationScience #MedicinalChemistry

🤝MedChemExpress on the Move | #EACR2026 European Association for Cancer Research (#EACR) @EACRnews fosters communication and collaboration within the global cancer research community, bringing together researchers to share groundbreaking insights in cancer science. We’re excited to join this inspiring event and connect with the oncology research community. 📅 Date: 8–11 June 2026 📍 Booth: No. 62 Visit Booth 62 to meet our team and explore how MedChemExpress can support your research and drug discovery. See you in Budapest 🇭🇺 #EACR #CancerResearch #Oncology #DrugDiscovery #LifeSciences #BiomedicalResearch #TranslationalMedicine

🧬Molecule of the Moment | #Retatrutide continues to stand out as one of the most closely watched candidates in metabolic disease research. Unlike GLP-1 receptor agonists, retatrutide is a first-in-class triple hormone receptor agonist that simultaneously targets: 🧬#GLP1 🧬#GIP 🧬#Glucagon Recent Phase 3 data showed: 📉Up to 28.3% mean weight loss over 80 weeks 📊Up to 2.0% A1C reduction in #T2D 🦴Improvements in obesity-related complications including knee osteoarthritis pain and obstructive sleep apnea 🧪MedChemExpress offers retatrutide for research use only: medchemexpress.com/retatruti… As obesity research expands beyond weight reduction alone, multi-receptor incretin therapies are emerging as a major area of innovation. #ADA2026 #ADA #EliLilly #Obesity #Type2Diabetes #Metabolism #DrugDiscovery #MedicinalChemistry

🧬Molecule of the Moment | #vopimetostat #daraxonrasib @TangoTxOncology reported encouraging early Phase 1/2 data for vopimetostat (#PRMT5 inhibitor) in combination with Revolution Medicines’ RAS(ON) inhibitor in #MTAP-deleted, RAS-mutant metastatic pancreatic ductal adenocarcinoma (#PDAC). 📊Key signals: • 92% ORR (11/12 patients) • 100% DCR • ~90% 6-month PFS In a tumor type long defined by therapeutic resistance, these results suggest true combination synergy rather than incremental benefit. Mechanistic rationale is converging: • #RAS(ON) inhibition → dampens oncogenic signaling • PRMT5 inhibition (MTAP-del context) → exploits synthetic lethality/metabolic vulnerability • Together → collapse of both signaling survival buffering ⚠️Still early: small cohorts, with key questions remaining around durability, resistance, and tolerability. The outcome goes beyond tumor shrinkage—hinting at early durability signals driven by combination biology. If validated, MTAP-del KRAS-mutant PDAC may become a case where tumor genotype defines a combination backbone, not just drug eligibility. Overall, the broader direction is becoming clearer: from single-node targeting → to coordinated pathway suppression in genomically defined tumors. 🔬MedChemExpress supports oncology research and drug discovery, enabling studies of key targets and emerging cancer pathways; for research use only, not for use in patients. Vopimetostat 👉 medchemexpress.com/tng-462.h… Daraxonrasib 👉 medchemexpress.com/rmc-6236.… #KRAS #PrecisionOncology #PancreaticCancer

🧬Molecule of the Moment from #ADA2026 | @EliLillyandCo's #Foundayo (#orforglipron), a non-peptide oral GLP-1 receptor agonist, delivered positive results across three pivotal Phase 3 #ACHIEVE trials in type 2 diabetes. 📊ACHIEVE-3 🔹Superior A1C reduction vs oral #semaglutide 🔹Superior weight loss vs oral semaglutide 📊ACHIEVE-2 & ACHIEVE-5 🔹Significant improvements in glycemic control 🔹Meaningful weight reduction across diverse patient populations 💡Unlike currently approved oral GLP-1 therapies, orforglipron is a small-molecule GLP-1 receptor agonist that can be administered without food or water restrictions. 📈Highlights the growing potential of oral, non-peptide incretin therapies As the #incretin field continues to evolve, oral GLP-1 receptor agonists remain one of the most closely watched areas in metabolic disease research. 🧪Explore GLP-1 receptor research tools from @MedChemExpress: medchemexpress.com/orforglip… #Type2Diabetes #GLP1 #Obesity #Endocrinology #DrugDiscovery #PharmaNews #Biotech #MedicinalChemistry

🧠Hot Off the Press | How does the brain remove unwanted proteins? The brain continuously clears protein waste to maintain homeostasis. A new study uses a genetic tracing system to track neuronal protein exit, revealing an organized clearance network. ✅ A non-invasive genetic system drives neuron-specific ZsGreen expression in 2–4-month-old mice, enabling in vivo tracking of protein clearance ✅ Brain clearance is compartmentalized and follows a “nearest exit” principle, determined by the anatomical origin of the protein ✅ Skull border tissues act as immune niches, containing tolerogenic B cells that sample brain-derived antigens ✅ Disease disrupts clearance via distinct mechanisms: • #Neuroinflammation causes vascular leakage and misrouting into the bloodstream • #Amyloid pathology leads to protein retention and impaired clearance 💡 The brain does not dump waste into a single exit pathway; instead, it routes molecules from different regions to specific boundary sites for clearance and immune processing. Brain clearance is a compartmentalized, organized network linking neuronal homeostasis, border immunity, and disease susceptibility. MedChemExpress supports #neurological research by enabling studies into brain clearance, neuroimmune interactions, and disease mechanisms. ow.ly/qutT50Z8GCO #Cell #Neuroscience #Neuroimmunology #BrainClearance #AlzheimersDisease #CNS #BrainHealth #Neurodegeneration

📚MedChemExpress Digest | The NLRP3–STING Axis in Neuroinflammation #Neuroinflammation is now recognized as a driver of neurodegeneration, not just a secondary response. It is better understood as a dynamic immune network shaped by diverse cellular states. The #NLRP3 inflammasome and cGAS–STING pathway form a connected inflammatory axis that converges on mitochondrial dysfunction and amplifies CNS #immune signaling. Key insights: • Neuroinflammation = cellular state remodeling, not simple activation • Single-cell studies reveal continuous immune state transitions • #Mitochondria act as a central hub linking NLRP3 and #STING signaling This creates a self-reinforcing inflammatory loop that contributes to neurodegeneration. Therapeutically, the field is shifting toward precision immune modulation, including targeting NLRP3–STING crosstalk and restoring mitochondrial function. Neuroinflammation is a network problem, not a single-pathway problem. Discover more: ow.ly/yoeq50Z7VA0 #Neurodegeneration #Immunology #InnateImmunity #Inflammasome #Neuroscience #SingleCell #TranslationalResearch #DrugDiscovery

💊#FDAApproval Update | The FDA has approved #INQOVI (#decitabine #cedazuridine) in combination with #venetoclax for adults with newly diagnosed #AML who are 75 years or older or ineligible for intensive induction chemotherapy. 🩸This approval marks the first and only all-oral treatment regimen for this AML patient population, potentially simplifying treatment and reducing reliance on infusion-based therapies. 📊The ASCERTAIN-V study: 🔹Complete remission (CR) rate: 41.6% 🔹Median time to CR: 2 months 🔹Median duration of CR was not reached at the time of analysis MedChemExpress offers decitabine, cedazuridine and venetoclax for research use only: medchemexpress.com/Decitabin… medchemexpress.com/cedazurid… medchemexpress.com/ABT-199.h… #Leukemia #AcuteMyeloidLeukemia #Hematology #Oncology #PharmaNews #DrugDiscovery #CancerResearch #MedicinalChemistry

🔥Stress isn’t just in your mind — it’s a full-body biological response. Can stress make you sick? Evidence suggests yes, through continuous brain–immune communication. 🧠This is the neuroimmune axis. Stress triggers a cascade: Hypothalamus → CRH → Pituitary → ACTH → Adrenal glands → Cortisol ↑ Under chronic stress: 👉 Immune cells release pro-inflammatory cytokines (IL-6, TNF-α) 👉 Persistent low-grade inflammation develops These immune signals don’t stay peripheral — they feed back to the brain, influencing mood, cognition, and behavior. It’s not just stress. It’s a whole-system biological response 🔁 #Stress #Neuroscience #Immunology #Neuroimmunology #Inflammation #MentalHealth #ScienceCommunication #BiomedicalResearch

💊#FDAApproval Update | Shionogi's #XOCOVA (#ensitrelvir) has been approved by the FDA as the first and only oral antiviral for post-exposure prevention of #COVID19🚨 💡XOCOVA is designed to help prevent symptomatic COVID-19 following exposure by blocking SARS-CoV-2 replication during the critical window before symptoms develop. 📊In the Phase 3 SCORPIO-PEP trial: 🔹Reduced the risk of symptomatic COVID-19 by 67% vs placebo 🔹First oral antiviral to meet its primary endpoint in post-exposure prophylaxis 🔹Effective regardless of vaccination status or prior immunity MedChemExpress offers ensitrelvir for research use only: medchemexpress.com/ensitrelv… #FDAApproval #LongCOVID #Antivirals #InfectiousDiseases #Virology #DrugDiscovery #PharmaNews #MedicinalChemistry

💊FDA Approval Update | The #FDA has approved #Imfinzi (#durvalumab) in combination with BCG for adults with high-risk non-muscle invasive bladder cancer (#NMIBC) who are unresponsive to BCG and ineligible for or decline radical cystectomy. Bladder cancer is one of the most common urologic malignancies, and patients with high-risk NMIBC face substantial risks of recurrence and progression despite standard BCG therapy. 💡Durvalumab, a PD-L1 checkpoint inhibitor, combined with BCG significantly improved complete response rates and durability of response, offering a bladder-preserving treatment option for a difficult-to-treat patient population. 📈A major milestone for #BladderCancer treatment and the continued expansion of immuno-oncology across disease stages. 🧪MedChemExpress offers durvalumab for research use only: medchemexpress.com/durvaluma… #FDAApproval #Oncology #CancerResearch #Immunotherapy #PharmaNews #DrugDiscovery #MedicinalChemistry

🔥Hot Off the Press | #APOE4 Across the #AD Continuum APOE4 is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD) and may directly drive disease progression in a stage-dependent manner. A recent review describes a cell-type– and stage-specific cascade: 🧠Stage 1: #Preclinical stage (20–30 years before symptoms) Early neuronal APOE4 expression leads to subtle network dysfunction, early amyloid/tau deposition, and silent long-term damage. ⚠️Stage 2: #Prodromal stage (MCI, ~3–5 years) Glial activation and chronic neuroinflammation accelerate pathology, with increasing amyloid and tau burden and emerging cognitive decline. 💔Stage 3: #Dementia stage Extensive neurodegeneration and brain atrophy result in severe cognitive and functional loss. 🔬Key insights • APOE4 has distinct roles across disease stages and cell types • Neuronal APOE4 may initiate early pathology • Glial APOE4 drives inflammation and progression in later stages • Chronic neuroinflammation is a central mechanism linking APOE4 to AD 💡Targeting APOE4 in a stage-specific and cell-specific manner may open new paths for precision therapies in AD. MedChemExpress provides 2,000 Alzheimer’s disease–related products to advance #neuroscience and AD research. ow.ly/8AAP50Z61gF #AlzheimersResearch #Neurodegeneration #Neuroinflammation #PrecisionMedicine #DrugDiscovery #AgingResearch

🧬#ASCO2026 Update | Personalized cancer vaccines continue to deliver At 5 years of follow-up, #Intismeran autogene (mRNA-4157/V940) #KEYTRUDA (#pembrolizumab) demonstrated: 🔹49% reduction in risk of recurrence or death 🔹59% reduction in risk of distant metastasis or death 🔹Encouraging trend toward improved overall survival 🚀Could individualized neoantigen vaccines become the next pillar of cancer immunotherapy? 🔗Read more: ascopubs.org/doi/10.1200/JCO… #Melanoma #CancerVaccine #mRNA #Immunotherapy #Oncology #Biotech #ASCO #ASCO26

🔥Hot Off the Press | 🧠New in Cell: A new spatiotemporal framework for developing human #meninges development 🔹Pia mater forms first during development 🔹A population of meningeal-specific macrophage was identified 🔹Pial fibroblasts recruit macrophages via CXCL12-CXCR4 signaling 🔹TREM2⁺ meningeal macrophages help regulate Cajal-Retzius cell development 🔹Dynamic neuroimmune interactions guide cortical formation Read more: cell.com/cell/abstract/S0092… #Neuroscience #DevelopmentalBiology #SpatialTranscriptomics #Neuroimmunology #TREM2